Clinical Trial Update: A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the safety of Degarelix (Firmagon) in Indian patients with advanced hormone-dependent prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED